Cancer Pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with cytologically or pathologically diagnosed malignant tumors, experiencing cancer pain at clearly defined sites. 2) Candidates suitable for topical medication, with no history of drug or food allergies. 3) Age =18 years and =85 years, with good compliance. 4) Expected survival period >12 weeks. 5) No dysfunction of major organs in the subjects, with normal blood counts, and normal liver, kidney, and cardiac functions. 6) Capable of comprehending the study details and providing signed informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients without a clear pathological diagnosis. 2) Patients currently undergoing or having completed radiotherapy/chemotherapy within less than 3–4 weeks. 3) Patients with an expected survival period of less than 3 months. 4) Patients complicated with severe diseases of the heart, liver, kidneys, hematopoietic system, or other major organs. 5) Patients with pregnancy confirmed by HCG testing or those who are lactating. 6) Patients with a history of psychiatric disorders that are difficult to manage.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NRS pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Equivalent Morphine Consumption;Security indicators; | — |
Countries
China
Contacts
Longhua hospital, Shanghai University of Traditional Chinese Medicine